03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Holoxan 500mg* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Abela Freres |
Distributor | Abela Freres |
Laboratory | Baxter |
Responsible Party | Baxter Oncology GmbH |
Origin | Germany |
Manufacturer | Baxter Oncology GmbH |
Origin | Germany |
ATC | L01AA06 |
Revision Date | 01/01/2002 |
Holoxan 500mg* :
Holoxan 500mg* :
Holoxan 500mg* :
Holoxan 500mg* :
Holoxan 500mg* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Holoxan 500mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Not known |
Acute leukaemia | Not known |
Acute lymphocytic leukaemia (Acute lymphoblastic leukemia) | Not known |
Acute respiratory distress syndrome | Not known |
Agranulocytosis | Not known |
Alopecia | Very Common |
Amenorrhoea (amenorrhea) | Not known |
Aminoaciduria | Not known |
Amnesia | Not known |
Anaemia | Not known |
Anaemia neonatal | Not known |
Anaphylactic reactions | Not known |
Angina pectoris | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Arrhythmia | Not known |
Arrhythmia supraventricular | Not known |
Arthralgia (Pain joint) (Joint ache) | Not known |
Asterixis | Not known |
Atrial fibrillation | Not known |
Azoospermia | Not known |
Bone marrow failure (Myelosuppression) | Very Common |
Bradycardia | Not known |
Capillary leak syndrome | Not known |
Cardiac arrest | Not known |
Cardiac failure | Not known |
Cardiomyopathy | Not known |
Cardiotoxicity | Uncommon |
Catatonia | Not known |
Chills | Not known |
Chronic renal insufficiency (Renal failure chronic) | Not known |
CNS toxicity | Not known |
Congestive cardiomyopathy | Not known |
Conjunctivitis | Not known |
Constipation | Not known |
Cough | Not known |
Cystitis haemorrhagic | Very Common |
Cytolytic hepatitis | Not known |
Deafness | Not known |
Decreased appetite | Common |
Deep vein thrombosis | Not known |
Delirium | Not known |
Delusion | Not known |
Dermatitis | Rare |
Diarrhoea (Diarrhea) | Uncommon |
Disseminated intravascular coagulation | Not known |
Dysarthria | Not known |
Dyspnoea (dyspnea) | Not known |
ECG QRS complex abnormal | Not known |
ECG ST segment abnormal | Not known |
ECG T wave inversion | Not known |
Echolalia | Not known |
Encephalopathy | Not known |
Enterocolitis | Not known |
Enuresis | Not known |
Erythema | Not known |
Extrapyramidal disorder | Not known |
Eye irritation | Not known |
Faecal incontinence | Not known |
Fanconi syndrome | Not known |
Fatigue | Uncommon |
Febrile bone marrow aplasia | Not known |
Feeling of residual urine | Not known |
Flushing | Not known |
Foetal growth restriction | Not known |
Gait disturbance | Not known |
Gastroduodenal haemorrhage | Not known |
General physical health deterioration | Not known |
Growth retardation | Not known |
Haematotoxicity | Not known |
Haematuria (Hematuria) | Very Common |
Haemolytic anemia | Not known |
Haemolytic uraemic syndrome (HUS) | Not known |
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) | Not known |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Not known |
Hepatotoxicity (liver toxicity) | Common |
Hyperglycaemia | Not known |
Hyperhidrosis | Not known |
Hypersensitivity reactions | Not known |
Hypertension | Not known |
Hypocalcaemia | Not known |
Hypoesthesia | Not known |
Hypokalaemia | Not known |
Hypophosphataemia | Not known |
Hypotension | Uncommon |
Hypoxia | Not known |
Ileus | Not known |
Immunosuppression | Not known |
Inappropriate antidiuretic hormone secretion (SIADH) | Not known |
Infection | Common |
Infection reactivation | Common |
Infertility | Not known |
Infusion site reactions | Not known |
Injection site reaction | Not known |
Interstitial lung disease | Not known |
Leucopenia (Leukopenia) | Very Common |
Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
Lymphoma | Not known |
Malaise | Not known |
Mania | Not known |
Metabolic acidosis | Not known |
Methemoglobinemia | Not known |
Movement disorder | Not known |
Mucosal ulceration | Not known |
Multi-organ failure | Not known |
Muscle twitching (Muscle twitch) | Not known |
Mutism | Not known |
Myalgia | Not known |
Myelodysplastic syndrome | Not known |
Myocardial haemorrhage | Not known |
Myocardial infarction | Not known |
Nail disorders | Not known |
Nausea | Very Common |
Nephrogenic diabetes insipidus | Not known |
Neuralgia | Not known |
Neuropathy peripheral | Not known |
Non-Hodgkin's lymphoma | Not known |
Oedema | Not known |
Oligospermia | Not known |
Osteomalacia | Not known |
Ovarian failure | Not known |
Ovulation disorder | Not known |
Pain | Not known |
Pancreatitis | Not known |
Panic attack | Not known |
Paraesthesia (paresthesia) | Not known |
Paranoia | Not known |
Perseveration | Not known |
Phlebitis | Common |
Pleural effusion | Not known |
Pneumonitis | Not known |
Polydipsia | Not known |
Polyuria | Not known |
Portal vein thrombosis | Not known |
Premature atrial contraction | Not known |
Premature menopause | Not known |
Pruritus | Not known |
Pulmonary embolism | Not known |
Pulmonary fibrosis | Not known |
Pulmonary hypertension | Not known |
Pulmonary oedema | Not known |
Pyrexia | Not known |
Radiation recall reaction (dermatologic) | Not known |
Rash papular | Rare |
Renal cell carcinoma | Not known |
Renal disorder | Very Common |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Very Common |
Respiratory failure | Not known |
Rhabdomyolysis | Not known |
Rickets | Not known |
Salivary hypersecretion | Not known |
Sarcoma | Not known |
Sepsis (Systemic infection) (Sepsis state) | Not known |
Septic shock | Not known |
Skin hyperpigmentation | Not known |
Skin necrosis | Not known |
Skin rash | Not known |
Status epilepticus | Not known |
Stevens-Johnson syndrome | Not known |
Stomatitis | Uncommon |
Swelling face | Not known |
Thrombocytopenia (Thrombopenia) | Very Common |
Thyroid cancer | Not known |
Tinnitus | Not known |
Tubulointerstitial nephritis | Not known |
Tumour lysis syndrome | Not known |
Urinary tract carcinoma in situ | Not known |
Urine phosphate increased | Not known |
Urticaria | Not known |
Vasculitis | Not known |
Venoocclusive liver disease | Not known |
Ventricular arrhythmia | Not known |
Vertigo | Not known |
Visual impairment | Not known |
Vomiting | Very Common |
Holoxan 500mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Holoxan 500mg* MoH 515 :
Form | Powder for solution for injection |
Packaging | Bottle |
Package Size | Box of 1 |
Strength | 500mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 27262 |
Submission date | 01/01/1992 |
Registration Year | 1992 |
Archived Date | 04/07/2023 |
Price Comparison
● Country: | Finland | |
● Package Size: | 1 | |
● Public Price: | 52.99 EUR | ( 5,133,459.24 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 52,99 EUR | ( 5,037,552.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Tunisia | |
● Package Size: | Boîte de 1 | |
● Public Price: | 161.2 TND | ( 4,653,038.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 161,2 TND | ( 4,647,265.00 LBP ) |
● Pricing Date: | 04/02/2019 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 1 | |
● Public Price: | 44.6 CHF | ( 4,612,532.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 44,6 CHF | ( 4,550,480.00 LBP ) |
● Exfactory Price: | 24.57 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Iceland | |
● Package Size: | 1 | |
● Public Price: | 4763 ISK | ( 3,072,135.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 4763 ISK | ( 3,072,135.00 LBP ) |
● Pharmacy Price: | 2398 ISK | ( 1546710 LBP ) |
● Reference: | Icelandic Medicines Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 1 | |
● Public Price: | 29.98 EUR | ( 2,904,342.48 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 29,98 EUR | ( 2,809,404.00 LBP ) |
● Pharmacy Price: | 22.98 EUR | ( 2226210.48 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | Czech Republic | |
● Package Size: | 1 | |
● Public Price: | 633.8 CZK | ( 2,420,482.20 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 633,8 CZK | ( 2,417,427.00 LBP ) |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 | |
● Type: | Medicine Authorised |
● Country: | Qatar | |
● Package Size: | 1 | |
● Public Price: | 88 QAR | ( 2,161,104.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 88 QAR | ( 2,161,104.00 LBP ) |
● Pharmacy Price: | 72.375278612 QAR | ( 1777392.0921535 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Norway | |
● Package Size: | 1 | |
● Public Price: | 246.3 NOK | ( 1,996,015.20 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 246,3 NOK | ( 1,993,584.00 LBP ) |
● Pharmacy Price: | 164.75 NOK | ( 1335134 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 1 | |
● Public Price: | 78.85 SAR | ( 1,864,014.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 78,85 SAR | ( 1,843,920.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 1 | |
● Public Price: | 11.77 JOD | ( 1,473,851.17 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 11,77 JOD | ( 1,377,431.00 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 1 | |
● Public Price: | 11.15 EUR | ( 1,080,167.40 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 11,15 EUR | ( 1,065,636.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 26/06/2017 | |
● Type: | Medicine Non Marketed |
● Country: | Turkey | |
● Package Size: | 1 | |
● Public Price: | 102.57 TRY | ( 274,887.60 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 102,57 TRY | ( 273,360.00 LBP ) |
● Pricing Date: | 28/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Greece |
● Package Size: | 1 |
● Reference: | National Organization for Medicines |
● Pricing Date: | 25/03/2019 |
● Type: | Medicine Non Marketed |
● Country: | Germany |
● Package Size: | 1 |
● Medica Comments: | Not available in the country of origin |
● Pricing Date: | 24/10/2020 |
● Type: | Medicine Non Marketed |
● Country: | Portugal |
● Package Size: | 1 |
● Reference: | Autoridade Nacional do Medicamento e Produtos de Saúde |
● Pricing Date: | 22/04/2019 |
● Country: | Denmark |
● Package Size: | 1 |
● Reference: | Danish Medicine Agency |
● Pricing Date: | 20/02/2019 |
● Type: | Medicine Non Marketed |
Note
You have to register to view this info
Drop File